Article preview from Medtech Insight - July, 2012
Brief summaries of recent medtech market and industry developments. This month we cover recent developments in renal denervation, which may be the next blockbuster device market, MindRay’s acquisition of China’s Wuhan Dragonbio Surgical Implant Co., and the GAO’s report on implantable device use by Medicare beneficiaries.
Article preview from Medtech Insight - July, 2012
This year’s EuroPCR conference, held in Paris in May, was definitely the coming out party for renal denervation (RDN), highlighting what many clinicians and industry executives point to as the next potential blockbuster device product market. In that way, RDN is following in the footsteps of transcatheter aortic valves (TAVI) and drug-eluting stents (DES), both of which were unveiled at previous EuroPCR meetings and remain important topics today, with numerous sessions on both at this year’s conference.
But renal denervation was clearly the belle of this year’s EuroPCR, with more than a dozen sessions on the topic (several of which were company-sponsored). In addition, just preceding the meeting, Covidien PLC announced its acquisition of RDN start-up Maya Medical Inc., and at the conference,St. Jude Medical Inc. unveiled its EnligHTN renal denervation system, which was prominently featured at the company’s large booth.
Indeed, the interest in renal denervation among large companies, start-ups, entrepreneurs and investors has taken on a life of its own, becoming the stuff of corporate myth to the point where it is getting hard to separate reality from exaggeration, most notably when it comes to the number of companies with RDN products and programs. A senior Medtronic Inc. executive estimated the number at 62, an estimate that has since been picked up in at least one analyst’s report, and is making its way through the industry grapevine. A senior Johnson & Johnson executive estimated the number at 42, lower but no less specific.
Continued...
To read this article in its entirety, purchase now as a PDF and receive it immediately via email. Or get it FREE when you subscribe to Medtech Insight Newsletter.
About Medtech Insight
Medtech Insight newsletter provides insights into the technology and market developments (devices, instrumentation, biomaterials, gene therapy, tissue engineering, etc.) impacting a wide range of surgical and non-surgical clinical practices.
Comments